Kallistatin: double-edged role in angiogenesis, apoptosis and oxidative stress
Authors:
- Julie ChaoJCJulie Chao
- Pengfei LiPLPengfei Li
- Lee ChaoLCLee Chao
- 25 July 2017
- journal article
- review article
- Published by Walter de Gruyter GmbH in Biological Chemistry
- Vol. 398 (12) , 1309-1317
Abstract
Kallistatin, via its two structural elements – an active site and a heparin-binding domain – displays a double-edged function in angiogenesis, apoptosis and oxidative stress. First, kallistatin has both anti-angiogenic and pro-angiogenic effects. Kallistatin treatment attenuates angiogenesis and tumor growth in cancer-bearing mice. Kallistatin via its heparin-binding site inhibits angiogenesis by blocking vascular endothelial growth factor (VEGF)-induced growth, migration and adhesion of endothelial cells. Conversely, kallistatin via the active site promotes neovascularization by stimulating VEGF levels in endothelial progenitor cells. Second, kallistatin inhibits or induces apoptosis depending on cell types. Kallistatin attenuates organ injury and apoptosis in animal models, and its heparin-binding site is essential for blocking tumor necrosis factor (TNF)-α-induced apoptosis in endothelial cells. However, kallistatin via its active site induces apoptosis in breast cancer cells by up-regulating miR-34a and down-regulating miR-21 and miR-203 synthesis. Third, kallistatin can act as an antioxidant or pro-oxidant. Kallistatin treatment inhibits oxidative stress and tissue damage in animal models and cultured cells. Kallistatin via the heparin-binding domain antagonizes TNF-α-induced oxidative stress, whereas its active site is crucial for stimulating antioxidant enzyme expression. In contrast, kallistatin provokes oxidant formation, leading to blood pressure reduction and bacterial killing. Kallistatin-mediated vasodilation is partly mediated by H2O2, as the effect is abolished by the antioxidant enzyme catalase. Moreover, kallistatin exerts a bactericidal effect by stimulating superoxide production in neutrophils of mice with microbial infection as well as in cultured immune cells. Thus, kallistatin’s dual roles in angiogenesis, apoptosis and oxidative stress contribute to its beneficial effects in various diseases.Keywords
This publication has 80 references indexed in Scilit:
- Anti-miR-203 Upregulates SOCS3 Expression in Breast Cancer Cells and Enhances Cisplatin ChemosensitivityGenes & Cancer, 2011
- Kallistatin attenuates endothelial apoptosis through inhibition of oxidative stress and activation of Akt-eNOS signalingAmerican Journal of Physiology-Heart and Circulatory Physiology, 2010
- Kallistatin Inhibits Vascular Inflammation by Antagonizing Tumor Necrosis Factor-α–Induced Nuclear Factor κB ActivationHypertension, 2010
- Inhibition of experimental lung metastasis by systemic lentiviral delivery of kallistatinBMC Cancer, 2010
- Pivotal role of JNK-dependent FOXO1 activation in downregulation of kallistatin expression by oxidative stressAmerican Journal of Physiology-Heart and Circulatory Physiology, 2010
- Circulating endothelial progenitor cells: a new approach to anti-aging medicine?Journal of Translational Medicine, 2009
- Kruppel-like Factor 4 Is a Novel Mediator of Kallistatin in Inhibiting Endothelial Inflammation via Increased Endothelial Nitric-oxide Synthase ExpressionJournal of Biological Chemistry, 2009
- MicroRNAs as New Players for Diagnosis, Prognosis, and Therapeutic Targets in Breast CancerJournal of Oncology, 2009
- MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosisRNA, 2008
- The relationship between angiogenesis and the immune response in carcinogenesis and the progression of malignant diseaseEuropean Journal of Cancer, 2000